BiomX (PHGE) Times Interest Earned (2018 - 2026)
BiomX (PHGE) posted Times Interest Earned of -$6.75 for Q1 2026, up 99.81% sequentially from -$3548.2 in Q4 2025, and up 99.04% YoY from -$3.39 in Q1 2025.
BiomX (PHGE) Times Interest Earned (2018 - 2026) Analysis & Trends
BiomX has reported Times Interest Earned for 8 years, with the latest figure at -$6.75 in Q1 2026.
- Quarterly Times Interest Earned rose 99.04% year-over-year to -$6.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$40.61 (up 99.02% YoY) and the FY2025 annual result came in at -$22.86, up 21.29% from the prior year.
- Times Interest Earned advanced to -$6.75 in Q1 2026 per PHGE's latest filing, from -$3548.2 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$6.75 in Q1 2026 and troughed at -$3548.2 in Q4 2025.
- A 5-year average of -$422.28 and a median of -$16.05 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2025 and 2026: Times Interest Earned tumbled 4732.19% in 2025, then surged 99.04% in 2026.
- Over 5 years, Times Interest Earned stood at -$111.2 in 2022, then soared by 90.88% to -$10.14 in 2023, then plunged by 1614.28% to -$173.8 in 2024, then slumped by 1941.52% to -$3548.2 in 2025, then jumped by 99.81% to -$6.75 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$6.75, -$3548.2, and -$776.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | -6.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.75 |
| Dec 31, 2025 | -3,548.20 |
| Sep 30, 2025 | -776.00 |
| Jun 30, 2025 | -825.89 |
| Mar 31, 2025 | -705.09 |
| Dec 31, 2024 | -173.80 |
| Sep 30, 2024 | -514.91 |
| Jun 30, 2024 | -17.09 |
| Dec 31, 2023 | -10.14 |
| Sep 30, 2023 | -13.58 |
| Jun 30, 2023 | -8.15 |
| Mar 31, 2023 | -10.99 |
| Dec 31, 2022 | -111.20 |
| Sep 30, 2022 | -11.80 |
| Jun 30, 2022 | -15.01 |
| Mar 31, 2022 | -7.92 |
| Dec 31, 2021 | -11.72 |
| Sep 30, 2021 | -2.21 |
| Dec 31, 2020 | -125.94 |
| Jun 30, 2020 | -1,065.67 |